Tenon Medical, Inc.
TNON
$1.11
$0.021.84%
| Weiss Ratings | TNON - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Very Weak | |||
| Risk Index | Weak | |||
| Risk Grade | D- | |||
| Reward Grade | E | |||
| Rating Factors | TNON - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Good | |||
| Efficiency Index | Very Weak | |||
| Solvency Index | Good | |||
| Total Return Index | Very Weak | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | TNON - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 2.60 | |||
| Price History | TNON - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -24.49% | |||
| 30-Day Total Return | -17.16% | |||
| 60-Day Total Return | -34.32% | |||
| 90-Day Total Return | -51.53% | |||
| Year to Date Total Return | -48.37% | |||
| 1-Year Total Return | -84.07% | |||
| 2-Year Total Return | -99.20% | |||
| 3-Year Total Return | -- | |||
| 5-Year Total Return | -- | |||
| 52-Week High % Change | -93.10% | |||
| 52-Week Low % Change | 19.85% | |||
| Price | TNON - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $15.79 | |||
| 52-Week Low Price | $0.91 | |||
| 52-Week Low Price (Date) | Mar 24, 2025 | |||
| 52-Week High Price (Date) | Sep 13, 2024 | |||
| Valuation | TNON - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 6.76M | |||
| Enterprise Value | 4.40M | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -22.80 | |||
| Earnings Per Share Growth | -72.27% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 1.05 | |||
| Price/Book (Q) | 1.54 | |||
| Enterprise Value/Revenue (TTM) | 1.34 | |||
| Price | $1.11 | |||
| Enterprise Value/EBITDA (TTM) | -0.33 | |||
| Enterprise Value/EBIT | -0.32 | |||
| Market Cap Category | Nano Cap | |||
| Dividends and Shares | TNON - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 3.15M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | TNON - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 408-649-5760 | |||
| Address | 104 Cooper Court Los Gatos, CA 95032 | |||
| Website | www.tenonmed.com | |||
| Country | United States | |||
| Year Founded | 2012 | |||
| Profitability | TNON - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -420.07% | |||
| Profit Margin | -417.24% | |||
| Management Effectiveness | TNON - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -106.30% | |||
| Return on Equity | -- | |||
| Income Statement | TNON - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 3.28M | |||
| Total Revenue (TTM) | 3.28M | |||
| Revenue Per Share | $1.04 | |||
| Gross Profit (TTM) | 1.71M | |||
| EBITDA (TTM) | -13.36M | |||
| EBIT (TTM) | -13.77M | |||
| Net Income (TTM) | -13.67M | |||
| Net Income Avl. to Common (TTM) | -13.67M | |||
| Total Revenue Growth (Q YOY) | -4.70% | |||
| Earnings Growth (Q YOY) | 1.50% | |||
| EPS Diluted (TTM) | -22.80 | |||
| EPS Diluted Growth (Q YOY) | 90.08% | |||
| Balance Sheet | TNON - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 6.54M | |||
| Cash Per Share (Q) | $2.08 | |||
| Total Current Assets (Q) | 8.21M | |||
| Total Preferred Equity (Q) | 3.75 | |||
| Total Equity (Q) | 5.97M | |||
| Current Ratio (Q) | 4.393 | |||
| Book Value Per Share (Q) | $0.71 | |||
| Total Assets (Q) | 9.84M | |||
| Total Current Liabilities (Q) | 1.87M | |||
| Total Debt (Q) | 428.00K | |||
| Total Liabilities (Q) | 3.87M | |||
| Total Common Equity (Q) | 2.22M | |||
| Cash Flow | TNON - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -186.00K | |||
| Cash from Financing (TTM) | 14.13M | |||
| Net Change in Cash (TTM) | 4.11M | |||
| Levered Free Cash Flow (TTM) | -4.65M | |||
| Cash from Operations (TTM) | -9.88M | |||
